Literature DB >> 3415105

Cutaneous vascular lesions and disseminated cat-scratch disease in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

J E Koehler1, P E LeBoit, B M Egbert, T G Berger.   

Abstract

Cutaneous lesions develop frequently in patients infected with human immunodeficiency virus (HIV). We describe the clinical features of four patients with the acquired immunodeficiency syndrome (AIDS) or AIDS-related complex who developed angiomatous nodules involving skin and bone, 2 of whom were scratched by a cat. Some of these lesions were clinically indistinguishable from Kaposi sarcoma. When examined with Warthin-Starry staining and electron microscopy, these nodules were noted to contain numerous clumps of a bacterium. Immunoperoxidase staining with an antiserum raised against the cat-scratch disease bacillus stained these organisms in all patients. Cat-scratch disease is usually a self-limited infection, but complicated or prolonged infections have been described in both normal and immunocompromised hosts. In our patients infected with HIV, manifestations of systemic cat-scratch disease included angiomatous nodules, severe systemic symptoms of fever, chills, night sweats and weight loss, elevated erythrocyte sedimentation rate, and decreased hematocrit. Cutaneous lesions involved the face, trunk, and extremities and numbered 2 to greater than 60; osseous lesions involved the fibula, radius, femur, and tibia, and were present in two of four patients. Treatment with x-ray therapy, intralesional vinblastine, penicillin, dicloxacillin, cephradine, and nafcillin had no effect on any lesions; however, treatment with erythromycin, doxycycline, or antimycobacterial antibiotics resulted in complete and rapid resolution of the cutaneous and osseous lesions, and the accompanying signs and symptoms of systemic infection. In patients with AIDS or AIDS-related complex, angiomatous nodules should be carefully evaluated for the presence of this organism, which can be treated and cured with antibiotic agents.

Entities:  

Mesh:

Year:  1988        PMID: 3415105     DOI: 10.7326/0003-4819-109-6-449

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  20 in total

Review 1.  Recommendations for treatment of human infections caused by Bartonella species.

Authors:  J M Rolain; P Brouqui; J E Koehler; C Maguina; M J Dolan; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

2.  Caring for pets of immunocompromised persons.

Authors:  F J Angulo; C A Glaser; D D Juranek; M R Lappin; R L Regnery
Journal:  Can Vet J       Date:  1995-04       Impact factor: 1.008

3.  Dermatology: cutaneous manifestations of human immunodeficiency virus infection.

Authors:  T G Berger
Journal:  West J Med       Date:  1989-12

Review 4.  Unraveling mysteries associated with cat-scratch disease, bacillary angiomatosis, and related syndromes.

Authors:  R Regnery; J Tappero
Journal:  Emerg Infect Dis       Date:  1995 Jan-Mar       Impact factor: 6.883

Review 5.  Bartonella spp. as emerging human pathogens.

Authors:  B E Anderson; M A Neuman
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

6.  In vitro evaluation of the role of humoral immunity against Bartonella henselae.

Authors:  M C Rodriguez-Barradas; J C Bandres; R J Hamill; J Trial; J E Clarridge; R E Baughn; R D Rossen
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

7.  Hepatic bacillary angiomatosis in a patient with AIDS.

Authors:  S H Wyatt; E K Fishman
Journal:  Abdom Imaging       Date:  1993

8.  Antibiotic susceptibilities of Afipia felis in axenic medium and in cells.

Authors:  M Maurin; H Lepocher; D Mallet; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

9.  Neurosurgical management of the acquired immunodeficiency syndrome. An update.

Authors:  B T Andrews; T P Kenefick
Journal:  West J Med       Date:  1993-03

10.  MICs of 28 antibiotic compounds for 14 Bartonella (formerly Rochalimaea) isolates.

Authors:  M Maurin; S Gasquet; C Ducco; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.